DVT Preventive Pump Market by Type, End User

Description

List of Tables

[183 Pages Report] The DVT Preventive Pump Market size was estimated at USD 383.06 million in 2023 and expected to reach USD 400.99 million in 2024, at a CAGR 4.81% to reach USD 532.58 million by 2030.

A DVT preventive pump is a medical device designed to prevent deep vein thrombosis (DVT). Deep vein thrombosis is a serious condition where blood clots form in the deep veins of the body, commonly in the legs. These clots can have severe consequences, such as blocking blood flow or breaking off and traveling to the lungs, causing a potentially fatal condition known as pulmonary embolism. Increasing recommendations by healthcare providers for DVT preventive measures for at-risk patients contribute to the growth of the DVT preventive pumps market. The high number of surgical procedures, which often lead to prolonged periods of immobility, further drives the need for DVT preventive devices. The high cost of DVT pumps and the availability of certain alternatives hamper the market growth. Rising innovations in DVT pump technology, such as enhanced comfort and ease of use that make these devices more appealing to both healthcare providers and patients are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 383.06 million
Estimated Year [2024]	USD 400.99 million
Forecast Year [2030]	USD 532.58 million
CAGR (%)	4.81%

Regional Insights

The market for DVT preventive pumps in the Americas is highly developing, with a significant adoption rate in clinical settings, particularly in the United States, Brazil, and Canada. This region shows stable growth due to the well-established healthcare infrastructure and high awareness of preventive treatments for DVT. Factors contributing to the market growth include the high prevalence of surgery-related immobility and obesity which are risk factors for DVT. Additionally, there are strict guidelines from healthcare authorities promoting the use of thrombosis-prevention devices. The APAC region is experiencing the fastest growth in the DVT preventive pump market, which is attributed to the rapidly developing healthcare sectors in countries such as China, India, and South Korea. Improvements in healthcare infrastructure, rising medical tourism, and increasing prevalence of lifestyle diseases that predispose individuals to DVT are significant drivers in this region. The EMEA region presents a diverse market scenario. Western European countries display a robust market presence similar to North America due to high healthcare standards and regulatory policies that support the adoption of DVT preventive pumps. Conversely, the Middle East and Africa exhibit growth, influenced by variable healthcare infrastructure and lower awareness about DVT prevention. Nonetheless, some countries in the Middle East show promising growth due to improving healthcare facilities and increasing government initiatives focused on healthcare.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the DVT Preventive Pump Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of deep vein thrombosis
- Supportive healthcare reforms and increasing insurance coverage

Market Restraints
- High cost associated with DVT prevention pumps

Market Opportunities
- Technology advancements in the development of more comfortable and user-friendly DVT prevention pumps
- Strategic partnerships and amalgamation activites

Market Challenges
- Concerns associated with product limitations and feature restrictions

Market Segmentation Analysis
- Type: Growing usage of intermittent pneumatic compression devices that mimics the natural rhythm of muscle contractions in the legs
- End User: High significance of DVT preventive pumps in hospitals & clinic across multiple departments

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the DVT Preventive Pump Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the DVT Preventive Pump Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

AIROS Medical Introduces Advanced AIROS 6P Compression Device for Comprehensive Lymphatic and Venous Treatment

AIROS Medical Inc. launched the AIROS 6P sequential compression device, complemented by specialized pants-like garments, designed to alleviate swelling in the abdomen, pelvis, and legs. This latest model, which follows the earlier release of the AIROS 8P, includes significant enhancements such as Peristaltic Mode functionality, which mimics natural wave-like muscle contractions, preferred for upper extremity treatments. The AIROS 6P, a 6-chamber pneumatic compression device, continues to be covered by Medicare and commercial insurers under HCPCS Code E0651, ensuring broad accessibility. [Published On: 2023-09-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the DVT Preventive Pump Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the DVT Preventive Pump Market, highlighting leading vendors and their innovative profiles. These include 3A Health Care S.R.L., Bio Compression Systems, Inc., Breg, Inc., Cardinal Health, Inc., Devon Medical Products, DJO Global, FlowAid Medical Technologies Corp., GE Healthcare, Huntleigh Healthcare Limited, Medline Industries, Inc., Medtronic PLC, Mego Afek ltd., NormaTec Industries LP, Oska Wellness, Smiths Medical, Stryker Corporation, SunTech Medical, Inc., Tactile Systems Technology Inc., Talley Group Limited, Vasomedical, Inc., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the DVT Preventive Pump Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Intermittent Pneumatic Compression Devices
- Sequential Compression Devices

End User
- Hospitals & Clinics
- Surgical Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-CD5A9334DABC

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of deep vein thrombosis
  - 5.1.1.2. Supportive healthcare reforms and increasing insurance coverage
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with DVT prevention pumps
- 5.1.3. Opportunities
  - 5.1.3.1. Technology advancements in the development of more comfortable and user-friendly DVT prevention pumps
  - 5.1.3.2. Strategic partnerships and amalgamation activites
- 5.1.4. Challenges
  - 5.1.4.1. Concerns associated with product limitations and feature restrictions
5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing usage of intermittent pneumatic compression devices that mimics the natural rhythm of muscle contractions in the legs
- 5.2.2. End User: High significance of DVT preventive pumps in hospitals & clinic across multiple departments
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. DVT Preventive Pump Market, by Type

6.1. Introduction
6.2. Intermittent Pneumatic Compression Devices
6.3. Sequential Compression Devices

7. DVT Preventive Pump Market, by End User

7.1. Introduction
7.2. Hospitals & Clinics
7.3. Surgical Centers

8. Americas DVT Preventive Pump Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific DVT Preventive Pump Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa DVT Preventive Pump Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
- 11.3.1. AIROS Medical Introduces Advanced AIROS 6P Compression Device for Comprehensive Lymphatic and Venous Treatment
11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

12.1. Key Company Profiles
12.2. Key Product Portfolio